{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T14:00:22Z","timestamp":1790085622687,"version":"4.0.1"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009729","name":"Ludwig Institute for Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009729","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"State of Sao Paulo Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.biopha.2026.119819","type":"journal-article","created":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T14:18:26Z","timestamp":1786717106000},"page":"119819","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Phenotype-driven screening of semi-synthetic terpene analogs identifies TRX-41 as a lead compound active in chemotherapy-resistant breast cancer organoids"],"prefix":"10.1016","volume":"203","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9395-2788","authenticated-orcid":false,"given":"Ariela","family":"Mo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"dos Santos e Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dijovani Batista","family":"Dos Reis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-3111-4915","authenticated-orcid":false,"given":"William Junior","family":"Santana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luma Soares","family":"De Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7694-7370","authenticated-orcid":false,"given":"Lucas Dam\u00e9","family":"Sim\u00f5es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuli T.","family":"Magalh\u00e3es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio Luis","family":"Forti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernande Xavier","family":"Dos Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda R.A.","family":"Canteli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina Rossi","family":"Saccarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larissa Assad Jo\u00e3o","family":"Moys\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ligia Akemi","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia Akissue","family":"de Camargo Teixeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9850-7090","authenticated-orcid":false,"given":"Thiago Yoshio","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera Christina Camargo","family":"de Siqueira Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian Larissa Nakamura","family":"Omura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentine","family":"De C\u00e1ssia Muller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa H.","family":"Farias Jandrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3927-0505","authenticated-orcid":false,"given":"Giulia Luiza","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilian Tiemi","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca Ventura","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0342-8726","authenticated-orcid":false,"given":"Roger","family":"Chammas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo Carlos S.D.","family":"de Barros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Luiz B.","family":"Bevilacqua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anamaria Aranha","family":"Camargo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela G.","family":"Giannotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3024-4247","authenticated-orcid":false,"given":"Mauricio Frota","family":"Saraiva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c9rico Tosoni","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.biopha.2026.119819_bib1","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1021\/acs.jnatprod.9b01285","article-title":"Natural products as sources of new drugs over the nearly four decades from 01\/1981 to 09\/2019","volume":"83","author":"Newman","year":"2020","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.biopha.2026.119819_bib2","doi-asserted-by":"crossref","DOI":"10.1038\/s41573-020-00114-z","article-title":"Natural products in drug discovery: advances and opportunities","author":"Atanasov","year":"2021","journal-title":"Nat. Rev. Drug. Discov."},{"key":"10.1016\/j.biopha.2026.119819_bib3","series-title":"Pharmacology","first-page":"167","article-title":"Terpenes","author":"Aldred","year":"2009"},{"key":"10.1016\/j.biopha.2026.119819_bib4","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1007\/s11064-018-2478-y","article-title":"Paeoniflorin inhibits migration and invasion of human glioblastoma cells via suppression transforming growth factor \u03b2-induced epithelial-mesenchymal transition","volume":"43","author":"Wang","year":"2018","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.biopha.2026.119819_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2022.109994","article-title":"Review of anticancer activity of monoterpenoids: geraniol, nerol, geranial and neral","volume":"362","author":"Silva","year":"2022","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.biopha.2026.119819_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.984849","article-title":"Editorial: Natural compounds as scaffolds for the discovery of new anti-cancer drugs: Focus on terpenoids and flavonoids","volume":"13","author":"S\u00fclsen","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2026.119819_bib7","doi-asserted-by":"crossref","DOI":"10.1007\/s43440-023-00512-1","article-title":"Anticancer effect of terpenes: focus on malignant melanoma","author":"Wr\u00f3blewska-\u0141uczka","year":"2023","journal-title":"Pharmacol. Rep."},{"issue":"7","key":"10.1016\/j.biopha.2026.119819_bib8","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.3390\/molecules30071480","article-title":"Biological activity of monoterpene-based scaffolds: a natural toolbox for drug discovery","volume":"30","author":"Mo\u0142doch","year":"2025","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.biopha.2026.119819_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0089892","article-title":"Use of synthetic isoprenoids to target protein prenylation and Rho GTPases in breast cancer invasion","volume":"9","author":"Chen","year":"2014","journal-title":"PLoS. One"},{"key":"10.1016\/j.biopha.2026.119819_bib10","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1093\/oxfordjournals.annonc.a058903","article-title":"Pacitaxel. and docetaxel (Taxotere): not simply two of a kind","volume":"v. 5","author":"Verweij","year":"1994","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.biopha.2026.119819_bib11","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/84570","article-title":"The story of taxol: nature and politics in the pursuit of an anti-cancer drug","volume":"7","author":"Miller","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.biopha.2026.119819_bib12","article-title":"Enhanced paclitaxel bioavailability after oral administration of pegylated paclitaxel prodrug for oral delivery in rats","author":"Choi","year":"2004","journal-title":"Int. J. Pharm."},{"issue":"6","key":"10.1016\/j.biopha.2026.119819_bib13","doi-asserted-by":"crossref","first-page":"733","DOI":"10.2174\/138945010791170842","article-title":"Targeting apoptosis pathway with natural terpenoids: implications for treatment of breast and prostate cancer","volume":"11","author":"Yang","year":"2010","journal-title":"Curr. Drug. Targets"},{"issue":"1","key":"10.1016\/j.biopha.2026.119819_bib14","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1186\/s12935-024-03558-0","article-title":"Comprehensive review of drug resistance in mammalian cancer stem cells: implications for cancer therapy","volume":"24","author":"Mengistu","year":"2024","journal-title":"Cancer Cell. Int."},{"issue":"3","key":"10.1016\/j.biopha.2026.119819_bib15","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1158\/2159-8290.CD-21-0212","article-title":"Independent drug action in combination therapy: implications for precision oncology","volume":"12","author":"Plana","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.biopha.2026.119819_bib16","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s40364-022-00356-6","article-title":"Clinical translation of patient-derived tumour organoids- bottlenecks and strategies","volume":"10","author":"Foo","year":"2022","journal-title":"Biomark. Res."},{"key":"10.1016\/j.biopha.2026.119819_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2023.1058970","article-title":"Primary human organoids models: current progress and key milestones","volume":"11","author":"Cal\u00e0","year":"2023","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.biopha.2026.119819_bib18","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1038\/s12276-024-01272-5","article-title":"Patient-derived tumor organoids: a new avenue for preclinical research and precision medicine in oncology","volume":"56","author":"Thorel","year":"2024","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.biopha.2026.119819_bib19","series-title":"OECD Guidelines for the Testing of Chemicals, Section 2","article-title":"Test No. 236: Fish Embryo Acute Toxicity (FET) Test","author":"OECD","year":"2025"},{"issue":"1-2","key":"10.1016\/j.biopha.2026.119819_bib20","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.cell.2017.11.010","article-title":"A living biobank of breast cancer organoids captures disease heterogeneity","volume":"172","author":"Sachs","year":"2018","journal-title":"Cell"},{"issue":"14","key":"10.1016\/j.biopha.2026.119819_bib21","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1158\/1078-0432.CCR-16-3083","article-title":"Clinically relevant concentrations of anticancer drugs: a guide for nonclinical studies","volume":"23","author":"Liston","year":"2017","journal-title":"Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.biopha.2026.119819_bib22","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nmeth.3853","article-title":"Growth rate inhibition metrics correct for confounders in measuring sensitivity to cancer drugs","volume":"13","author":"Hafner","year":"2016","journal-title":"Nat. Methods"},{"issue":"4","key":"10.1016\/j.biopha.2026.119819_bib23","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"issue":"n. 6","key":"10.1016\/j.biopha.2026.119819_bib24","doi-asserted-by":"crossref","first-page":"827","DOI":"10.3390\/ph16060827","article-title":"Application of zebrafish as a model for anti-cancer activity evaluation and toxicity testing of natural products","volume":"v. 16","author":"Shen","year":"2023","journal-title":"Pharmaceuticals"},{"issue":"D1","key":"10.1016\/j.biopha.2026.119819_bib25","doi-asserted-by":"crossref","first-page":"D730","DOI":"10.1093\/nar\/gkae1113","article-title":"The STRING database in 2025: protein networks with directionality of regulation","volume":"53","author":"Szklarczyk","year":"2025","journal-title":"Nucleic Acids Res."},{"issue":"3","key":"10.1016\/j.biopha.2026.119819_bib26","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1365-2125.2012.04223.x","article-title":"Cyclophosphamide and 4-hydroxycyclophosphamide pharmacokinetics in patients with glomerulonephritis secondary to lupus and small vessel vasculitis","volume":"74","author":"Joy","year":"2012","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.biopha.2026.119819_bib27","doi-asserted-by":"crossref","first-page":"5986","DOI":"10.3390\/molecules25245986","article-title":"A compressive review about Taxol\u00ae: history and future challenges","volume":"25","author":"Gallego-Jara","year":"2020","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.biopha.2026.119819_bib28","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41573-020-00114-z","article-title":"Natural products in drug discovery: advances and opportunities","volume":"20","author":"Atanasov","year":"2021","journal-title":"Nat. Rev. Drug. Discov."},{"issue":"9","key":"10.1016\/j.biopha.2026.119819_bib29","article-title":"Therapeutic potential of terpenoids in cancer treatment: targeting mitochondrial pathways","volume":"7","author":"Guo","year":"2024","journal-title":"Cancer Rep (Hoboken)"},{"issue":"1","key":"10.1016\/j.biopha.2026.119819_bib30","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/s41698-025-00990-x","article-title":"The role of tumor necrosis factor receptor superfamily in cancer: insights into oncogenesis, progression, and therapeutic strategies","volume":"9","author":"Xu","year":"2025","journal-title":"NPJ Precis. Oncol."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226008553?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226008553?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T13:07:11Z","timestamp":1790082431000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332226008553"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":30,"alternative-id":["S0753332226008553"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119819","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phenotype-driven screening of semi-synthetic terpene analogs identifies TRX-41 as a lead compound active in chemotherapy-resistant breast cancer organoids","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119819","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119819"}}